Home LiteratureArticle Details
PMID: 8621481 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Dissecting clot retraction and platelet aggregation. Clot retraction does not require an intact fibrinogen gamma chain C terminus.

The Journal of biological chemistry ·Vol. 271 ·No. 15 ·1996-04-12 ·Pages 8553-5

Rooney MM, Parise LV, Lord ST

Abstract

Fibrinogen mediates the processes of platelet aggregation and clot retraction. Previous studies have demonstrated that fibrinogen binding to the platelet receptor alphaIIbbeta3 requires the C-terminal residues of the fibrinogen gamma chain. We made a recombinant human fibrinogen that lacks the gamma chain C-terminal four residues (AGDV). As expected this fibrinogen did not support platelet aggregation. Unexpectedly, this variant did support clot retraction that was indistinguishable from retraction with normal recombinant or plasma fibrinogen. These results suggest that the site on fibrinogen that is required for platelet aggregation differs from the site on fibrin that is required for clot retraction.

MeSH Terms
Adenosine Diphosphate/metabolism Amino Acid Sequence Blood Platelets/physiology Clot Retraction Fibrinogen/chemistry Humans Molecular Sequence Data Platelet Aggregation Sequence Deletion Structure-Activity Relationship
Chemicals
Adenosine Diphosphate Fibrinogen
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rooney M M
Department of Chemistry, University of North Carolina, Chapel Hill, 27599-7525, USA.
Parise L V
Lord S T
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1996-04-12
Pages
8553-5
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NHLBI NIH HHS · HL45100 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]